文献速递冠心病

高危PCI术后ACS与非ACS患者的常规负荷试验:POST-PCI随机试验二次分析

Routine Stress Testing After PCI in Patients With and Without Acute Coronary Syndrome: A Secondary Analysis of the POST-PCI Randomized Clinical Trial.
PubMed 文献 · JAMA Cardiol · 2024-01-01

POST-PCI随机试验二次分析纳入1706例高危PCI患者,30.8%为ACS,比较术后12个月常规功能负荷试验与单纯标准随访。ACS患者2年主要复合终点风险较非ACS高55%(HR 1.55),但无论ACS状态,常规负荷试验均未显著改善2年结局。

要点

  • ACS患者PCI术后第一年不良事件风险更高,2年主要复合终点HR 1.55。

核心结论

  • 高危PCI术后ACS患者早期不良事件风险高于非ACS患者,但12个月常规负荷试验未带来增量获益。

研究设计与样本

  • POST-PCI为随机临床试验,2017年11月至2019年9月从韩国11个中心入选高危PCI患者。
  • 共纳入1706例患者,平均年龄64.7(10.3)岁,女性350例(20.5%),ACS 526例(30.8%)。
  • 患者按ACS与非ACS分层后随机接受术后12个月常规功能负荷试验或单纯标准随访。

主要发现

  • ACS患者2年主要复合终点风险较非ACS高55%(HR 1.55;95%CI 1.03-2.33;P=.03),源于第一年事件率更高。
  • ACS患者2年主要终点发生率:负荷试验组16/251(6.6%),标准随访组23/275(8.5%);HR 0.76(95%CI 0.40-1.44;P=.39)。
  • 非ACS患者2年主要终点发生率:负荷试验组30/598(5.1%),标准随访组28/582(4.9%);HR 1.04(95%CI 0.62-1.74;P=.88)。
  • ACS状态与随访策略交互作用P=.45;landmark分析提示负荷试验组1年后侵入性造影和再次血运重建率较高,但交互作用不显著。

关键数值与推荐

  • 主要终点为随机化后2年全因死亡、心肌梗死或不稳定型心绞痛住院的复合终点。

临床怎么用

  • 对高危PCI术后患者,尤其ACS患者,术后第一年应加强临床随访。
  • 不建议仅因ACS病史在术后12个月常规安排功能负荷试验。

局限性

  • 原文摘要未报告局限性相关内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: The appropriate follow-up surveillance strategy for patients with acute coronary syndrome (ACS) who have undergone percutaneous coronary intervention (PCI) remains unknown. OBJECTIVE: To assess clinical outcomes in patients with and without ACS who have undergone high-risk PCI according to a follow-up strategy of routine stress testing at 12 months after PCI vs standard care alone. DESIGN, SETTING, AND PARTICIPANTS: The POST-PCI (Pragmatic Trial Comparing Symptom-Oriented vs Routine Stress Testing in High-Risk Patients Undergoing Percutaneous Coronary Intervention) trial was a randomized clinical trial that compared follow-up strategies of routine functional testing vs standard care alone 12 months after high-risk PCI. Patients were categorized as presenting with or without ACS. Patients were enrolled in the trial from November 2017 through September 2019, and patients were randomized from 11 sites in South Korea; data analysis was performed in 2022. INTERVENTION: Patients categorized as presenting with or without ACS were randomized to either a routine functional testing or standard care alone follow-up strategy 12 months after high-risk PCI. MAIN OUTCOMES AND MEASURES: The primary outcome was a composite of death from any cause, myocardial infarction, or hospitalization for unstable angina at 2 years following randomization. Kaplan-Meier event rates through 2 years and Cox model hazard ratios (HRs) were generated, and interactions were tested. RESULTS: Of 1706 included patients, 350 patients (20.5%) were female, and the mean (SD) patient age was 64.7 (10.3) years. In total, 526 patients (30.8%) presented with ACS. Compared with those without ACS, patients with ACS had a 55% greater risk of the primary outcome (HR, 1.55; 95% CI, 1.03-2.33; P = .03) due to higher event rates in the first year. The 2-year incidences of the primary outcome were similar between strategies of routine functional testing or standard care alone in patients with ACS (functional testing: 16 of 251 [6.6%]; standard care: 23 of 275 [8.5%]; HR, 0.76; 95% CI, 0.40-1.44; P = .39) and in patients without ACS (functional testing: 30 of 598 [5.1%]; standard care: 28 of 582 [4.9%]; HR, 1.04; 95% CI, 0.62-1.74; P = .88) (P for interaction for ACS = .45). Although a landmark analysis suggested that the rates of invasive angiography and repeat revascularization were higher after 1 year in the routine functional testing group, the formal interactions between ACS status and either invasive angiography or repeat revascularization were not significant. CONCLUSION AND RELEVANCE: Despite being at higher risk for adverse clinical events in the first year after PCI than patients without ACS, patients with ACS who had undergone high-risk PCI did not derive incremental benefit from routine surveillance stress testing at 12 months compared with standard care alone during follow-up. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03217877.

来源:JAMA Cardiol,查看原文。版权归原作者所有。

引用

  1. Lee, Kang, Kim, et al. Routine Stress Testing After PCI in Patients With and Without Acute Coronary Syndrome: A Secondary Analysis of the POST-PCI Randomized Clinical Trial. JAMA Cardiol. 2024. PMID: 38922632. doi:10.1001/jamacardio.2024.1556

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。